type here...

CATEGORIES

Clinical Trials

LATEST

123Page 2 of 3

TRENDING

EDITORS CHOICE

Health Possibilities We Can’t Afford to Block

Gil Bashe, Medika Life Editor -
Fixing one piece of the healthcare puzzle is encouraging - but is it transformational? Here are 10 things we can consider to make things better.

Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

Medika Life -
CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

Texas: Pediatric Migraine Clinical Study Participants – Children

Medika Life -
Apply to Cedar Health to participate in a Pediatric Migraine study This study is open to children suffering from migraine. Pediatric studies

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

Medika Life -
Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived a heart attack

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories